e Cell invasion by human papillomavirus type 16 (HPV16) is a complex process relying on multiple host cell factors. Here we describe an investigation into the role of cellular protein disulfide isomerases (PDIs) by studying the effects of the commonly used PDI inhibitor bacitracin on HPV16 infection. Bacitracin caused an unusual time-dependent opposing effect on viral infection. Enhanced cellular binding and entry were observed at early times of infection, while inhibition was observed at later times postentry. Bacitracin was rapidly taken up by host cells and colocalized with HPV16 at late times of infection. Bacitracin had no deleterious effect on HPV16 entry, capsid disassembly, exposure of L1/L2 epitopes, or lysosomal trafficking but caused a stark inhibition of L2/viral DNA (vDNA) endosomal penetration and accumulation at nuclear PML bodies. ␥-Secretase has recently been implicated in the endosomal penetration of L2/vDNA, but bacitracin had no effect on ␥-secretase activity, indicating that blockage of this step occurs through a ␥-secretase-independent mechanism. Transient treatment with the reductant -mercaptoethanol (-ME) was able to partially rescue the virus from bacitracin, suggesting the involvement of a cellular reductase activity in HPV16 infection. Small interfering RNA (siRNA) knockdown of cellular PDI and the related PDI family members ERp57 and ERp72 reveals a potential role for PDI and ERp72 in HPV infection.
Human papillomaviruses (HPVs) are one of the most common sexually transmitted infections in the world. HPVs are small 55-nm icosahedral nonenveloped double-stranded DNA (dsDNA) viruses that replicate in differentiating cutaneous and mucosal epithelium. Infection of mucosal epithelium by oncogenic HPV genotypes can lead to cervical, anogenital, and other head and neck cancers. HPV type 16 (HPV16) is the most common of the high-risk types and is alone responsible for over 50% of cervical cancers worldwide (77). Although HPVs have been known to be the etiological agent of cervical cancer for nearly 30 years, and despite intensive research in recent years, the infectious entry pathway of HPV16 is still not well defined. Our current understanding of HPV cellular invasion reveals a complex and prolonged process, complicated by differences between in vitro cell culture systems and the recently described in vivo mouse cervicovaginal challenge model (33,37,50,62).The HPV capsid is assembled from 360 molecules of the L1 protein, arranged as 72 pentamers. L1 monomers from neighboring pentamers are disulfide bonded to each other as dimers and trimers, providing stability to the capsid (45). The minor capsid protein L2 is localized within a central cavity beneath the L1 pentamers. L2 can be present at a maximum stoichiometry of one L2 molecule per L1 pentamer or 72 molecules per virion; however, most preparations of virus contain submaximal levels of L2, typically 20 to 25 copies per virion (6). Packaged within the capsid is the ϳ8-kb viral genome (viral DNA [vDNA]), condensed as chromatin with cellu...